~11 spots leftby Oct 2025

Distal Pharyngeal Airway for Oxygenation During Procedures

FG
Overseen byFouad G Souki, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Miami
Disqualifiers: Uncontrolled GERD, Airway obstruction, others
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial is testing a new flexible tube called the McMurray Enhanced Airway (MEA) to help people breathe better. It aims to see if this tube can deliver oxygen more effectively than the usual method. The MEA is designed to reach deeper into the throat, which might improve oxygen levels in patients who need it.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Distal Pharyngeal Airway for Oxygenation During Procedures?

The study on Transnasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) with a nasopharyngeal airway showed that it effectively kept the airway open during anesthesia-induced apnea, suggesting that similar airway devices can help maintain oxygen levels during procedures.12345

Is the Distal Pharyngeal Airway safe for use in humans?

The Distal Pharyngeal Airway (DPA) is designed to prevent airway obstruction during procedures, especially in patients with higher risk factors like older age and sleep apnea. While specific safety data for the DPA is not detailed, it is intended to maintain ventilation, suggesting a focus on safety in its design.678910

How is the McMurray Enhanced Airway treatment different from other airway management treatments?

The McMurray Enhanced Airway (MEA) is unique because it is designed to stent open the distal pharyngeal tissues, preventing airway obstruction during procedures, especially in patients with conditions like obstructive sleep apnea. This is different from other airway devices that may not specifically target the distal pharyngeal area to maintain ventilation.69111213

Research Team

FG

Fouad G Souki, MD

Principal Investigator

University of Miami

Eligibility Criteria

This trial is for adults aged 18 or older who are scheduled for an elective Transesophageal Echocardiography (TEE) procedure and can give informed consent. It's not suitable for those with uncontrolled acid reflux or anatomical airway blockages, or any condition that might interfere with the study.

Inclusion Criteria

I am willing to join the study and can give my consent.
I am scheduled for a TEE (heart ultrasound) procedure.
I am 18 years old or older.

Exclusion Criteria

Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements
I have uncontrolled acid reflux.
I have a blockage in my airways.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo a TEE procedure with either the McMurray Enhanced Airway or a nasal cannula for oxygen delivery

up to 60 minutes

Follow-up

Participants are monitored for safety and effectiveness after the procedure

1 week

Treatment Details

Interventions

  • McMurray Enhanced Airway (Procedure)
  • Nasal Cannula (Procedure)
Trial OverviewThe study is testing if the McMurray Enhanced Airway (MEA), a special flexible airway device, provides better oxygenation during TEE than the standard nasal cannula, which is a tube placed in the nostrils.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Distal Pharyngeal AirwayExperimental Treatment1 Intervention
Participants in this group will use the McMurray enhanced airway to have oxygen delivered throughout a TEE procedure for up to 60 minutes.
Group II: Nasal cannula groupActive Control1 Intervention
Participant in this group will receive oxygen through a nasal cannula during the TEE procedure for up to 60 minutes.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+
Sylvia Daunert profile image

Sylvia Daunert

University of Miami

Chief Executive Officer since 2011

PhD in Biochemistry and Molecular Biology, University of Kentucky

Bahar Motlagh profile image

Bahar Motlagh

University of Miami

Chief Medical Officer since 2021

PhD in Biomedical Engineering, Ecole Polytechnique Montreal

Findings from Research

In a study involving 123 patients, the use of a nasopharyngeal airway (NPA) was found to be noninferior to the jaw thrust technique for maintaining airway opening during anesthesia-induced apnea, as measured by oxygen (PaO2) and carbon dioxide (PaCO2) levels after 20 minutes.
Both methods effectively maintained safe oxygen levels (PaO2) and prevented dangerous carbon dioxide buildup (PaCO2), with no patients experiencing oxygen saturation below 90%, indicating that NPA is a safe alternative for airway management in this context.
Transnasal Humidified Rapid Insufflation Ventilatory Exchange With Nasopharyngeal Airway Facilitates Apneic Oxygenation: A Randomized Clinical Noninferiority Trial.Chen, L., Yang, L., Tian, W., et al.[2020]
Maxillomandibular advancement (MMA) surgery significantly increased the size of the pharynx during sleep by 66% in patients with obstructive sleep apnea, indicating improved airway space.
Post-surgery, the variability in the pharyngeal measurements decreased from 117.5% to 51%, suggesting enhanced stability of the airway and a reduced risk of pharyngeal collapse during sleep.
Dynamic comparison of pharyngeal stability during sleep in patients with obstructive sleep apnea syndrome treated with maxillomandibular advancement.Faria, AC., Garcia, LV., Santos, AC., et al.[2022]
The Jaw-Thrust-Device significantly improved expiratory tidal volumes and peak inspiratory flow during facemask ventilation compared to the standard Esmarch manoeuvre in a study of 50 healthy adults.
It also outperformed both nasopharyngeal and oropharyngeal airways in reducing airway resistance, indicating its potential as a more effective tool for maintaining airway patency during anesthesia induction.
Optimising the unprotected airway with a prototype Jaw-Thrust-Device--a prospective randomised cross-over study.von Goedecke, A., Mitterschiffthaler, L., Paal, P., et al.[2009]

References

Transnasal Humidified Rapid Insufflation Ventilatory Exchange With Nasopharyngeal Airway Facilitates Apneic Oxygenation: A Randomized Clinical Noninferiority Trial. [2020]
Dynamic comparison of pharyngeal stability during sleep in patients with obstructive sleep apnea syndrome treated with maxillomandibular advancement. [2022]
Optimising the unprotected airway with a prototype Jaw-Thrust-Device--a prospective randomised cross-over study. [2009]
Volumetric analysis of the pharynx in patients with obstructive sleep apnea (OSA) treated with maxillomandibular advancement (MMA). [2022]
[Clinical study on modified maxillomandibular advancement for the treatment of obstructive sleep apnea syndrome]. [2019]
Introducing the First Distal Pharyngeal Airway. [2023]
The clinical effectiveness of the streamlined liner of pharyngeal airway (SLIPA) compared with the laryngeal mask airway ProSeal during general anesthesia. [2022]
Airway Complications during and after General Anesthesia: A Comparison, Systematic Review and Meta-Analysis of Using Flexible Laryngeal Mask Airways and Endotracheal Tubes. [2018]
Anaesthesia for adenotonsillectomy: a comparison between tracheal intubation and the armoured laryngeal mask airway. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Comparison of the Laryngeal Mask Airway ProSeal and the Streamlined Liner of the Pharynx Airway During General Anesthesia: A Systematic Review and Meta-analysis. [2023]
ProSeal laryngeal mask airway improves oxygenation when used as a conduit prior to laryngoscope guided intubation in bariatric patients. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Successful pharyngeal pulse oximetry in low perfusion states. [2004]
[Experiences with use of the laryngeal mask with flexible, wire reinforced tube for ENT interventions in childhood]. [2013]